
William Plovanic
Stock Analyst at Canaccord Genuity
(3.66)
# 2,092
Out of 5,184 analysts
698
Total ratings
44.1%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Maintained: Hold | $374 | $320.91 | +16.54% | 32 | Nov 17, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Buy | $40 | $20.07 | +99.30% | 17 | Nov 16, 2026 | |
| HTFL HeartFlow | Reiterated: Buy | $56 → $69 | $48.46 | +42.39% | 16 | Nov 13, 2026 | |
| TLSI TriSalus Life Sciences | Reiterated: Buy | $7 → $4 | $2.43 | +64.61% | 24 | Nov 11, 2026 | |
| CVRX CVRx, Inc. | Downgraded: Hold | $5 → $2 | $0.6074 | +229.27% | 41 | Nov 9, 2026 | |
| AORT Artivion | Reiterated: Buy | $40 → $30 | $19.10 | +57.07% | 16 | Nov 6, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | $196 → $206 | $91.91 | +124.13% | 38 | Nov 6, 2026 | |
| PLSE Pulse Biosciences | Reiterated: Buy | $58 → $74 | $50.44 | +46.71% | 5 | Nov 6, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $94 → $120 | $91.38 | +31.32% | 60 | Nov 6, 2026 | |
| EW Edwards Lifesciences | Reiterated: Hold | $85 → $97 | $107.15 | -9.47% | 41 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $67 | $56.84 | +17.87% | 39 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $33 | $26.14 | +26.24% | 16 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $179 | $152.48 | +17.39% | 45 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $44.34 | +8.25% | 46 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $18 | $10.66 | +68.86% | 3 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $16 | $7.07 | +126.31% | 9 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $97 | $83.33 | +16.40% | 46 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $6.08 | +64.47% | 3 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.39 | +115.83% | 30 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 → $79 | $72.14 | n/a | 20 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $25 | $23.44 | n/a | 3 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $19 | $11.87 | n/a | 10 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $55.93 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $295 → $300 | $309.64 | n/a | 22 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 → $131 | $103.21 | n/a | 14 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $31.28 | n/a | 6 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $27.68 | n/a | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $48 → $43 | $26.39 | n/a | 17 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $86 → $70 | $86.63 | n/a | 17 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $20 | $2.86 | n/a | 10 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.8278 | n/a | 7 | Feb 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.21 | n/a | 11 | Jan 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $4.06 | n/a | 6 | Nov 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $22 | - | n/a | 7 | Jul 29, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0003 | n/a | 6 | Feb 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $63 | $91.32 | n/a | 7 | Jun 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $14 | $7.40 | n/a | 4 | Jul 31, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $7.17 | n/a | 1 | Sep 9, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.40 | n/a | 1 | Jun 28, 2011 |
Penumbra
Nov 17, 2026
Maintained: Hold
Price Target: $374
Current: $320.91
Upside: +16.54%
Tandem Diabetes Care
Nov 16, 2026
Maintained: Buy
Price Target: $40
Current: $20.07
Upside: +99.30%
HeartFlow
Nov 13, 2026
Reiterated: Buy
Price Target: $56 → $69
Current: $48.46
Upside: +42.39%
TriSalus Life Sciences
Nov 11, 2026
Reiterated: Buy
Price Target: $7 → $4
Current: $2.43
Upside: +64.61%
CVRx, Inc.
Nov 9, 2026
Downgraded: Hold
Price Target: $5 → $2
Current: $0.6074
Upside: +229.27%
Artivion
Nov 6, 2026
Reiterated: Buy
Price Target: $40 → $30
Current: $19.10
Upside: +57.07%
iRhythm Holdings
Nov 6, 2026
Reiterated: Buy
Price Target: $196 → $206
Current: $91.91
Upside: +124.13%
Pulse Biosciences
Nov 6, 2026
Reiterated: Buy
Price Target: $58 → $74
Current: $50.44
Upside: +46.71%
TransMedics Group
Nov 6, 2026
Reiterated: Buy
Price Target: $94 → $120
Current: $91.38
Upside: +31.32%
Edwards Lifesciences
Nov 5, 2026
Reiterated: Hold
Price Target: $85 → $97
Current: $107.15
Upside: -9.47%
Nov 4, 2026
Reiterated: Buy
Price Target: $55 → $67
Current: $56.84
Upside: +17.87%
Nov 4, 2026
Reiterated: Buy
Price Target: $26 → $33
Current: $26.14
Upside: +26.24%
Nov 4, 2026
Reiterated: Buy
Price Target: $179
Current: $152.48
Upside: +17.39%
Nov 3, 2026
Reiterated: Buy
Price Target: $48
Current: $44.34
Upside: +8.25%
Nov 3, 2026
Reiterated: Buy
Price Target: $7 → $18
Current: $10.66
Upside: +68.86%
Oct 30, 2026
Reiterated: Buy
Price Target: $25 → $16
Current: $7.07
Upside: +126.31%
Oct 30, 2026
Reiterated: Buy
Price Target: $90 → $97
Current: $83.33
Upside: +16.40%
Oct 29, 2026
Reiterated: Buy
Price Target: $10
Current: $6.08
Upside: +64.47%
Apr 6, 2026
Reiterated: Buy
Price Target: $3
Current: $1.39
Upside: +115.83%
Jan 22, 2024
Reiterated: Buy
Price Target: $71 → $79
Current: $72.14
Upside: n/a
Jan 22, 2024
Reiterated: Buy
Price Target: $24 → $25
Current: $23.44
Upside: n/a
Dec 21, 2023
Reiterated: Buy
Price Target: $17 → $19
Current: $11.87
Upside: n/a
Dec 21, 2023
Reiterated: Buy
Price Target: $15
Current: $55.93
Upside: n/a
Dec 15, 2023
Reiterated: Hold
Price Target: $295 → $300
Current: $309.64
Upside: n/a
Dec 15, 2023
Reiterated: Hold
Price Target: $150 → $131
Current: $103.21
Upside: n/a
Nov 30, 2023
Reiterated: Hold
Price Target: $32
Current: $31.28
Upside: n/a
Nov 7, 2023
Reiterated: Buy
Price Target: $65
Current: $27.68
Upside: n/a
Sep 15, 2023
Reiterated: Hold
Price Target: $48 → $43
Current: $26.39
Upside: n/a
Aug 28, 2023
Reiterated: Hold
Price Target: $86 → $70
Current: $86.63
Upside: n/a
Feb 23, 2023
Reiterated: Buy
Price Target: $16 → $20
Current: $2.86
Upside: n/a
Feb 2, 2016
Reiterated: Buy
Price Target: $8
Current: $0.8278
Upside: n/a
Jan 11, 2016
Reiterated: Buy
Price Target: $12
Current: $3.21
Upside: n/a
Nov 5, 2015
Reiterated: Buy
Price Target: $16
Current: $4.06
Upside: n/a
Jul 29, 2015
Reiterated: Hold
Price Target: $25 → $22
Current: -
Upside: n/a
Feb 2, 2015
Reiterated: Hold
Price Target: n/a
Current: $0.0003
Upside: n/a
Jun 5, 2014
Reiterated: Buy
Price Target: $73 → $63
Current: $91.32
Upside: n/a
Jul 31, 2013
Reiterated: Hold
Price Target: $17 → $14
Current: $7.40
Upside: n/a
Sep 9, 2011
Reiterated: Buy
Price Target: $45
Current: $7.17
Upside: n/a
Jun 28, 2011
Reiterated: Buy
Price Target: n/a
Current: $14.40
Upside: n/a